The Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer brings together thought leaders in seven key areas of biomedical research to focus on molecular-based approaches to cancer diagnosis and treatment.
The Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer brings together thought leaders in seven key areas of biomedical research to focus on molecular-based approaches to cancer diagnosis and treatment.
Hundreds of Researchers Interacting for a Common Purpose
- Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer - Samir Hanash, M.D., Ph.D., Director
- Metastasis Research Center
- Center for Cancer Immunology Research
- Center for Radiation Oncology Research
- Center for Advanced Biomedical Imaging
- Center for Targeted Therapy
- Center for RNA Interference and Non-coding RNAs
- Center for Global Cancer Early Detection
Did You Know?
Red and Charline McCombs and their daughters, Marsha, Connie and Lynda, have given cancer researchers a tool for scientific discovery that has great promise to accelerate the rate at which new patient-focused advances are made. To thank them for their generosity, the institute was named in their honor.
Help Innovative Research
The institute's interconnected programs offer you a chance to help at a historic moment in the long search for answers to cancer.
Contact Us
Additional information about the Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer and ways to provide philanthropic support can be obtained by contacting McCombsInfo@mdanderson.org.
Sam Hanash, M.D., Ph.D.
Professor and Director, McCombs Institute
Jennifer Dennison, Ph.D.
Director, Research Planning and Development, McCombs Institute
The University of Texas MD Anderson Cancer Center
6767 Bertner Ave, Unit 1013
Houston, Texas 77030
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.